MBAI · Check-Cap Ltd
$1.07
At close · Jul 27
Market Cap
$8.27M
Shares
7.73M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.07
Open$1.11
Day$1.05–1.13
52W$0.59–3.92
Avg vol 30d66K
Short int78K · 1.0% float · 1.2d
Short vol26%
DataJan 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.66
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−34%
below
Price vs 50-day avg
−23%
below
RSI (14)
43
neutral
MACD trend
Positive
52-week position
14%
near low
Momentum
relative strength
1-month return
−4%
trailing
6-month return
−36%
trailing
YTD return
−34%
this year
Relative strength
−43%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Distributing
4 of 14 funds reported for Jun 30 · net -15 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.00% of float · ▼ -11.3% MoM · 1.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
14 holders — mid 3-yr range
Squeeze score
39
low risk · 0–100
Fundamentals
EPS growth
+115%
Y/Y
Free cash flow
$-129.0K
Balance sheet
$2.0K
net cash
Quant / Vol
risk profile
Volatility
241%
annualized · 1-yr
Max drawdown
−70%
past year
ATR
9.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−34%
Bearish
Price vs 50-day avg
−23%
Bearish
RSI (14)
43
Neutral
MACD trend
Positive
Bullish
52-week position
14%
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Distributing
4 of 14 funds reported for Jun 30 · net -15 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.00% of float · ▼ -11.3% MoM · 1.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
14 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1
Now $1 · 14%
52-wk high $4
vs 200-day avg -34%
vs 50-day avg -23%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MBAI
this stock
Check-Cap Ltd
|
$8.27M | -34.0% | — | — | 1.0% |
|
TMO
Thermo Fisher Scientific Inc.
|
$207.93B | -3.3% | +0.4% | 30.8 | 1.4% |
|
DHR
Danaher Corp /De/
|
$138.14B | -13.8% | +8.5% | 34.8 | 1.4% |
|
IDXX
Idexx Laboratories Inc /De
|
$43.87B | -17.8% | +10.4% | 40.9 | 2.7% |
|
A
Agilent Technologies, Inc.
|
$38.94B | +1.8% | +6.4% | 27.7 | 2.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
13
- % held
- 0.4%
- Reported
- 4 of 14
- Top holder
- UBS Group AG
Held
Float
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MBAI | +7.0% | -3.6% | -36.3% | -14.4% | -34.0% |
| SPY | -0.6% | +0.7% | +6.8% | -1.0% | +8.4% |
| vs SPY | +7.6% | -4.3% | -43.1% | -13.4% | -42.3% |